Incyte to Report Fourth Quarter and Year-End 2021 Financial Results
January 18 2022 - 8:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
fourth quarter and year-end 2021 financial results conference call
and webcast for 8:00 a.m. ET on Tuesday, February 8, 2022.
The schedule for the press release and conference call/webcast
is as follows:
• Q4 & YE 2021 Press Release:
February 8, 2022 at 7:00 a.m.
ET
• Q4 & YE 2021 Conference Call:
February 8, 2022 at 8:00 a.m.
ET
• Domestic Dial-In Number:
877-407-3042
• International Dial-In Number:
201-389-0864
• Conference ID Number:
13726298
If you are unable to participate, a replay of the conference
call will be available for ninety days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay you
will need the conference ID number 13726298.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for 90
days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical
company focused on finding solutions for serious unmet medical
needs through the discovery, development and commercialization of
proprietary therapeutics. For additional information on Incyte,
please visit Incyte.com and follow @Incyte.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220118005069/en/
Incyte Media Catalina
Loveman +1 302 498 6171 cloveman@incyte.com
Investors Christine Chiou +1 302 274 4773
cchiou@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2023 to Jul 2024